USPTO serial 79326559
ALBAJUNA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 21, 2023
- Examiner
- TULLY, MATTHEW
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ALBAJUNA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ashly I. Boesche
Ashly I. Boesche Pattishall, McAuliffe, Newbury, Hilliard200 S. Wacker Drive, Suite 2900Chicago, IL 60606UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations, namely, recombinant therapeutics for the treatment of HIV/AIDS; biological preparations for medical use, namely, recombinant therapeutics for the treatment of HIV/AIDS; antiviral preparations, namely, recombinant therapeutics being pharmaceutical preparations in the nature of antivirals; pharmaceutical products for the treatment of HIV/AIDS; chemical, analysis and diagnostic reagents for medical research and for medical and veterinary use in diagnostics; diagnosis preparations for medical purposes, namely, medical diagnostic reagents; diagnostic testing materials for medical use, namely, diagnostic kits comprised of medical diagnostic recombinant reagents and assays for detecting diseases | ACTIVE | — |
| 041 | Educational services, namely, providing training in the field of medical and pharmaceutical products; organization and conducting of seminars, conferences, congresses, symposiums and training workshops in the field of medical and pharmaceutical products; online publication of books and journals in the field of medical and pharmaceutical products in electronic form, being publishing services; practical training in the field of medicine and pharmaceutical products; publication of texts other than advertising texts in the field of medicine and pharmaceutical products | ACTIVE | — |
| 042 | Pharmaceutical research and development; medical research in the field of recombinant therapeutics; clinical research services in the field of pharmaceuticals, namely, recombinant therapeutics; laboratory research services relating to pharmaceuticals; research and development services relating to new pharmaceutical products; laboratory materials analysis services being medical and scientific laboratory services; chemical analysis; scientific laboratory services; laboratory testing services, namely, medical and scientific laboratory services; medical research laboratory services; research and development services relating to pharmaceutical substances; technical consultancy in the pharmaceutical sector, namely, consulting services in the field of pharmaceutical research and development; online and in-person information and advisory services relating to the aforesaid | ACTIVE | — |
| 044 | Monitoring of patients, namely, monitoring of medical data for medical diagnosis and treatment; advice in the field of beauty care; psychological assistance for patients; providing medical and health information about medical disorders; providing medical and health information about infection control; medical services for psychological counseling; patient support services in the nature of medical services relating to the treatment of medical disorders; medical services; providing health information; information and advisory services relating to pharmaceutical products, namely, medical and pharmaceutical consultation; online and in-person information and advisory services relating to the aforesaid | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ALBAJUNA THERAPEUTICS, S.L.
- Other trademarks owned by ALBAJUNA THERAPEUTICS, S.L.
- Other trademarks owned by ALBAJUNA THERAPEUTICS, S.L.
- Other trademarks in Class 005
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named ALBAJUNA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 13, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 24, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 24, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 21, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 21, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Feb 21, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 12, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Dec 6, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 6, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 23, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 23, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Nov 16, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 2, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 2, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 2, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 2, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 2, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 2, 2022 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Sep 20, 2022 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Sep 6, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 6, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 6, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 6, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 6, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 26, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 25, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 25, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 26, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 1, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 1, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 29, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 28, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 24, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 15, 2022 | CORN | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Jan 9, 2022 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Dec 3, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 29, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 25, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |